Stocksigma LogoStocksigma Logo

Panacea Biotec Board to Consider Q2 Results on 14th Nov'26

Panacea Biotec announced that a meeting of its Board of Directors is scheduled for 14th Nov'26 to consider and approve the standalone and consolidated

Panacea Biotec Board to Consider Q2 Results on 14th Nov'26

Panacea Biotec Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Panacea Biotec Board to Consider Q2 Results on 14th Nov'26 Panacea Biotec announced that a meeting of its Board of Directors is scheduled for 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company confirmed that the trading window for designated persons and their immediate relatives remains closed from 1st Oct'26 through 16th Nov'26 in compliance with insider trading regulations.

Original exchange filing (PDF)

More announcements from Panacea Biotec Ltd

All Panacea Biotec Ltd announcements